Philip W. Kantoff

机构：Memorial Sloan Kettering Cancer Center, Convergent Science (United States) · ORCID：0000-0001-7275-0597

发表论文 1362 篇 · 总被引 92296 次 · h-index 136

代表论文

Assessing the contribution of rare protein-coding germline variants to prostate cancer risk and severity in 37,184 cases (2025 · Nature Communications · 被引 16)
Refining Risk Stratification of High-risk and Locoregional Prostate Cancer: A Pooled Analysis of Randomized Trials (2024 · European Urology · 被引 13)
Germline DNA Damage Repair Variants and Prognosis of Patients with High-Risk or Metastatic Prostate Cancer (2024 · Clinical Cancer Research · 被引 10)
Prognostic significance of PSA>0.2 after 6-12 months treatment for metastatic hormone-sensitive prostate cancer (mHSPC) intensified by androgen-receptor pathway inhibitors (ARPI): A multinational real-world analysis of the IRONMAN registry. (2025 · Journal of Clinical Oncology · 被引 6)
Identifying Patients at Risk of Early Lethal Prostate Cancer by Integrating Family History, Polygenic Risk Score, Rare Variants in DNA Repair Genes, and Lifestyle Factors (2025 · European Urology Oncology · 被引 4)
Characterising the contribution of rare protein-coding germline variants to prostate cancer risk and severity in 37,184 cases (2024 · medRxiv · 被引 4)